Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation

Background/purpose: Chemoradiation (CRT) is standard therapy for locally advanced cervical cancer (LACC). However, there is a lack of biomarkers to identify patients at high relapse-risk. We examine metabolic (glucose transporter-1 [Glut-1]), hypoxic (hypoxia inducible factor [HIF-1α]; carbonic anhy...

Full description

Bibliographic Details
Main Authors: Yada Kanjanapan, Siddhartha Deb, Richard J. Young, Mathias Bressel, Linda Mileshkin, Danny Rischin, Michael S. Hofman, Kailash Narayan, Shankar Siva
Format: Article
Language:English
Published: Elsevier 2017-02-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630816300325